The Company

Laxxon Medical is a pharma-technology company pioneering cutting-edge 3D screen printing development and manufacturing solutions for the pharmaceutical industry. Laxxon was founded in 2017 by a team of medical and business professionals, all of whom have 20+ years experience in the pharmaceutical industry. Our highly skilled team provides comprehensive pharmaceutical services to pharmaceutical partners including R&D, IP, and regulatory services. Laxxon is headquartered in New York City with research and development facilities in Jena, Germany. We are in the process of establishing a state-of-the-art GMP lab and production facilities in the US with our partner, Evonik Industries.

The Technology

Laxxon’s SPID®-Technology (Screen Printing Innovational Drug Technology) is a cutting-edge patented 3D screen printing technology which facilitates different pharmaceutical forms of application such as  oral, transdermal, and implantable dosage forms through geometric shaping and heterogeneous distribution of active ingredients. SPID®-Technology is capable of printing small batches for R&D, up to commercial-scale production (up to 1.5MM units per day) without the need to change the manufacturing process.

The Mission

Laxxon is dedicated to revolutionizing the pharmaceutical industry through better, faster and cost-effective solutions which mutually benefit the patient and the industry.

The Solutions

Laxxon’s business model is based upon a three-solution framework:

Laxxon's state of the art pharmacutical manufacturing facility
Pharmacist examines Laxxon's patented SPID technology

Helmut Kerschbaumer

Chief Executive Officer

Klaus

Kühne

Chief Operations Officer

Alex

Ruckdaeschel

Chief Strategy Officer

Achim

Schneeberger Ph.D

Chief Science Officer

Marjorie

Bailey

Chief Financial Officer

Edward

Kay

Board Member

Victoria

Boyle-Hebron

Board Member

Board of Directors

Laxxon Lab.png

About

Laxxon Medical

Laxxon Medical is disrupting the current pharmaceutical drug delivery and manufacturing landscape through our innovative, patented SPID®-Technology (Screen Printing Innovational Drug Technology).

Stay
Informed

Subscribe for updates on our latest developments.

Thanks for submitting!

Contact Us

We're always eager to chat with potential investors and industry partners. Contact us for any additional information you need.

Thanks for submitting!

All Rights Reserved © 2022 by Laxxon Medical

  • Twitter
  • LinkedIn

135 E 57th Street,

New York, New York 10022

Contact Us

We're always eager to chat with potential investors and industry partners. Contact us for any additional information you need.